BOYS, Mark Laurence,BRADLEY, Michael F.,DELISLE, Robert Kirk,HENNINGS, D. David,KENNEDY, April L.,MARMSATER, Fredrik P.,MEDINA, Matthew David,MUNSON, Mark C.,RAST, Bryson,RIZZI, James P.,RODRIGUEZ, Ma
申请号：
MEP9914
公开号：
ME01894B
申请日:
2010.12.20
申请国别(地区):
ME
年份:
2014
代理人:
摘要：
Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which R1, R2, R3, R4 and R5 have the meanings given in the specification, are inhibitors of cFMS and are useful in the treatment of bone-related diseases, cancer, autoimmune disorders, inflammatory diseases, cardiovascular diseases and pain.text
